Sean Harper, M.D. is a Co-Founding Managing Director of Westlake Village BioPartners. At Westlake he has invested in companies such as Latigo and Recludix. Previously, Dr. Harper served in several roles at Amgen culminating as Executive Vice President of Research and Development and was Senior Director of Clinical Genomics at Merck Research Laboratories.
Named by Time as one of the 50 most influential people in healthcare in 2018, Harper has helped bring over a dozen novel therapies to patients for the treatment of cancer, osteoporosis, cardiovascular disease and migraine. He received his M.D. from the University of California at San Francisco, completed internal medicine and gastroenterology training at the Massachusetts General Hospital, and was a postdoctoral fellow in the laboratory of Phillip A. Sharp at the Massachusetts Institute of Technology. He studied Biomedical Sciences at the University of California, Riverside and holds a B.S. in Medical Sciences from University of San Francisco.